IOVANCE BIOTHERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Earnings Per Share, Basic and Diluted of -$0.51 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-06
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.51.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.47.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.40.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.47.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.88.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$1.59.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.27.
- IOVANCE BIOTHERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.41.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.51 10-Q · filed 2021-05-06 | |||||||
| 2020-12-31 | -$0.47 10-K · filed 2021-02-25 | -$1.88 10-K · filed 2021-02-25 | ||||||
| 2020-09-30 | -$0.40 10-K · filed 2021-02-25 | -$1.41 10-Q · filed 2020-11-05 | ||||||
| 2020-06-30 | -$0.47 10-K · filed 2021-02-25 | -$1.02 10-Q · filed 2020-08-06 | ||||||
| 2020-03-31 | -$0.55 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | -$0.50 10-K · filed 2021-02-25 | -$1.59 10-K · filed 2021-02-25 | ||||||
| 2019-09-30 | -$0.40 10-K · filed 2021-02-25 | -$1.08 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | -$0.38 10-K · filed 2021-02-25 | -$0.68 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | -$0.30 10-K · filed 2021-02-25 | |||||||
| 2018-12-31 | -$0.27 10-K · filed 2020-02-25 | -$1.27 10-K · filed 2021-02-25 | ||||||
| 2018-09-30 | -$0.36 10-K · filed 2020-02-25 | -$1.01 10-Q · filed 2019-11-04 | ||||||
| 2018-06-30 | -$0.34 10-K · filed 2020-02-25 | -$0.65 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | -$0.31 10-K · filed 2020-02-25 | |||||||
| 2017-12-31 | -$0.36 10-K · filed 2019-02-28 | -$705.27 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.41 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | -$0.35 10-K · filed 2019-02-28 | -$1.06 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | -$0.37 10-K · filed 2019-02-28 | -$0.71 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | -$0.33 10-K · filed 2019-02-28 | |||||||
| 2016-12-31 | -$0.25 10-K · filed 2018-03-12 | -$1384.00 derived: net income ÷ weighted average shares · filed 2019-02-28 | -$1.85 10-K · filed 2019-02-28 | |||||
| 2016-09-30 | -$1.15 10-K · filed 2018-03-12 | -$1.64 10-Q · filed 2017-11-02 | ||||||
| 2016-06-30 | -$0.23 10-K · filed 2018-03-12 | -$0.37 10-Q · filed 2017-08-03 | ||||||
| 2016-03-31 | -$0.14 10-K · filed 2018-03-12 | |||||||
| 2015-12-31 | -$0.17 10-K · filed 2017-03-09 | -$0.18 10-K · filed 2016-03-11 | -$336.09 derived: net income ÷ weighted average shares · filed 2018-03-12 | -$0.62 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$0.16 10-K · filed 2017-03-09 | -$0.44 10-Q · filed 2016-11-04 | ||||||
| 2015-06-30 | -$0.14 10-K · filed 2017-03-09 | -$0.28 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | -$0.14 10-K · filed 2017-03-09 | |||||||
| 2014-12-31 | -$0.17 10-K · filed 2016-03-11 | -$0.48 10-K · filed 2017-03-09 | ||||||
| 2014-09-30 | -$0.11 10-K · filed 2016-03-11 | -$0.30 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$0.09 10-K · filed 2016-03-11 | -$0.19 10-Q · filed 2015-08-10 | ||||||
| 2014-03-31 | -$0.11 10-K · filed 2016-03-11 | |||||||
| 2013-12-31 | -$3.47 10-K · filed 2016-03-11 | |||||||
| 2013-09-30 | -$0.66 10-Q · filed 2014-11-13 | -$1.97 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | -$4.19 10-Q · filed 2014-08-08 | -$0.01 10-Q · filed 2013-10-23 | -$1.54 10-Q · filed 2014-08-08 | -$0.01 10-Q · filed 2013-10-23 | ||||
| 2013-03-31 | -$1.28 10-Q · filed 2014-05-14 | $1.28 10-Q · filed 2013-10-23 | ||||||
| 2012-12-31 | -$4.14 10-K · filed 2014-03-28 | -$0.04 10-K · filed 2013-09-23 | ||||||
| 2012-09-30 | -$0.86 10-Q · filed 2013-11-14 | -$0.01 10-Q · filed 2013-01-25 | -$8.66 10-Q · filed 2013-11-14 | -$0.09 10-Q · filed 2013-01-25 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2013-10-23 | -$0.08 10-Q · filed 2013-10-23 | ||||||
| 2012-03-31 | $7.39 10-Q · filed 2013-10-23 | $0.07 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | -$0.34 10-K · filed 2013-09-23 | |||||||
| 2011-09-30 | -$0.07 10-Q · filed 2013-01-25 | -$0.23 10-Q · filed 2013-01-25 | ||||||
| 2011-06-30 | -$0.15 10-Q/A · filed 2012-09-10 | -$0.16 10-Q/A · filed 2012-09-10 | ||||||
| 2011-03-31 | -$0.01 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$0.02 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | -$0.01 10-Q · filed 2011-11-21 | -$0.01 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-01 | $0.00 10-Q/A · filed 2011-09-01 | ||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |